Nisa Investment Advisors Boosts AbbVie Stake by 43%

The investment firm now holds $156 million in AbbVie shares.

Apr. 1, 2026 at 10:34am

Got story updates? Submit your updates here. ›

Nisa Investment Advisors LLC increased its stake in pharmaceutical giant AbbVie Inc. (NYSE: ABBV) by 42.8% during the fourth quarter, according to a recent 13F filing with the Securities and Exchange Commission. The institutional investor now owns 682,721 shares of AbbVie's stock, valued at nearly $156 million.

Why it matters

AbbVie is a major player in the pharmaceutical industry, known for blockbuster drugs like Humira. Nisa Investment Advisors' increased stake suggests the firm sees long-term growth potential in AbbVie's business and product pipeline.

The details

According to the 13F filing, Nisa Investment Advisors purchased an additional 204,761 shares of AbbVie during the fourth quarter, bringing its total position to 682,721 shares. This represents 2.2% of Nisa's total investment portfolio, making AbbVie the firm's 14th largest holding.

  • Nisa Investment Advisors increased its AbbVie stake during the fourth quarter of 2025.
  • The 13F filing detailing the increased position was submitted on April 1, 2026.

The players

Nisa Investment Advisors LLC

An institutional investment firm that manages over $156 million in AbbVie shares.

AbbVie Inc.

A global biopharmaceutical company known for blockbuster drugs like Humira.

Got photos? Submit your photos here. ›

The takeaway

Nisa Investment Advisors' increased stake in AbbVie suggests the firm sees long-term growth potential in the pharmaceutical company's business and product pipeline, underscoring AbbVie's status as a major player in the industry.